STEPHANIE PENNY: Open Payments
NPI 1447251830 · NEWBERRY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 9 payments from 7 companies in 2025. Trend: 2023 $435 · 2024 $514 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $43 |
| Lilly USA, LLC | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| LNHC, Inc | 1 | $21 |
| GENZYME CORPORATION | 1 | $17 |
| Incyte Corporation | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: OTEZLA, ZEPBOUND, Rhapsido, ZELSUVMI, DUPIXENT, OPZELURA, RINVOQ.
Industry payments across FL — which companies pay providers there.
